Cerebral amyloid angiopathy-related hemorrhage in a middle-aged patient with Down's syndrome

References

• Mrak R E, Griffin W S. Trisomy 21 and the brain. J Neuropathol Exp Neurol 2004; 63: 679–685
   PubMed Web of Science ®Google Scholar
• Wisniewski K E, Wisniewski H M, Wen G Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985; 17: 278–282
   PubMed Web of Science ®Google Scholar
• Wisniewski K E, Dalton A J, McLachlan C, Wen G Y, Wisniewski H M. Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology 1985; 35: 957–961
   PubMed Web of Science ®Google Scholar
• Ikeda S, Yanagisawa N, Allsop D, Glenner G G. Evidence of amyloid β-protein immunoreactive early plaque lesion in Down's syndrome brains. Lab Invest 1989; 61: 133–137
   PubMed Web of Science ®Google Scholar
• Tokuda T, Fukushima T, Ikeda S, Sekijima Y, Shoji S, Yanagisawa N, Tamaoka A. Plasma levels of amyloid β proteins Aβ1-40 and Aβ1-42(43) are elevated in Down's syndrome. Ann Neurol 1997; 41: 271–273
   PubMedGoogle Scholar
• Gilbert J J, Vinters H V. Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 1983; 14: 915–923
   PubMed Web of Science ®Google Scholar
• Vinter H V. Cerebral amyloid angiopathy: a critical review. Stroke 1987; 18: 311–324
   PubMedGoogle Scholar
• Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 2005; 110: 345–359
   PubMed Web of Science ®Google Scholar
• Belza M G, Urich H. Cerebral amyloid angiopathy in Down's syndrome. Clin Neuropathol 1986; 5: 257–260
   PubMedGoogle Scholar
• Donahue J E, Khurana J S, Adelman L S. Intracerebral hemorrhage in two patients with Down's syndrome and cerebral amyloid angiopathy. Acta Neuropathol 1998; 95: 213–216
   PubMedGoogle Scholar
• Mccarron M O, Nicoll J AR, Graham D I. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors. J Neurol Neurosurg Psychiatry 1998; 65: 405–406
   PubMedGoogle Scholar
• Lopez J R, Infante E R, Montero J LM, Carretero M JM. Cerebral amyloid angiopathy, recurrent intracerebral haemorrhages and Down's syndrome. Neurologia 2006; 21: 729–732
   PubMedGoogle Scholar
• Ellis R J, Olichney J M, Thal L J, Mirra S S, Morris J C, Beekly D, Heyman A. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, part XV. Neurology 1996; 46: 1592–1596
   PubMed Web of Science ®Google Scholar
• Vonsattel J PG, Myers R H, Hedley-Whyte E T, Ropper A H, Bird E D, Richardson E P, Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991; 30: 637–649
   PubMed Web of Science ®Google Scholar
• Greenberg S M, Briggs M E, Hyman B T, Kokoris G J, Takis C, Kanter D S, Kase C S, Pessin M S. Apolipoprotein Eϵ4 is associated with the presence and earlier onset of haemorrhage in cerebral amyloid angiopathy. Stroke 1996; 27: 1333–1337
   PubMed Web of Science ®Google Scholar
• Nicoll J A, Burnett C, Love S, Graham D I, Dewar D, Ironside J W, Stewart J, Vinters H V. High frequency of apolipoprotein E allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997; 41: 716–721
   PubMed Web of Science ®Google Scholar
• Scholl T, Stein Z, Hansen H. Leukaemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976. Dev Med Child Neurol 1982; 24: 817–829
   PubMedGoogle Scholar
• Van Gool W A, Evenhuis H M, van Duijn C M. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Ann Neurol 1995; 38: 225–230
   PubMedGoogle Scholar
• Wisniewski T, Morelli L, Wegiel J, Levy E, Wisniewski H M, Frangione B. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Ann Neurol 1995; 37: 136–138
   PubMedGoogle Scholar
• Hardy J, Crook R, Perry R, Raghavan R, Roberts G. ApoE genotype and Down's syndrome. Lancet 1994; 343: 979–980
   PubMedGoogle Scholar
• Sekijima Y, Ikeda S, Tokuda T, Satoh S, Hidaka H, Hidaka E, Ishikawa M, Yanagisawa N. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome. Eur Neurol 1998; 39: 234–237
   PubMed Web of Science ®Google Scholar